Capital World Investors’s IN8bio INAB Stock Holding History

Capital World Investors’s Portfolio INAB Stock Details INAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-25,825	Closed	-$1.88M	–	555
2022 Q2	$1.88M	Sell	25,825 -842	-3%	-$71.2K	﹤0.01%	524
2022 Q1	$2.78M	Hold	26,667	–	–	﹤0.01%	547
2021 Q4	$3.51M	Hold	26,667	–	–	﹤0.01%	578
2021 Q3	$5.52M	Buy	+26,667	New	+$6.63M	﹤0.01%	579

Other funds holding INAB

Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return

SIG

Stonegate Investment Group Birmingham, Alabama $4.31B AUM 18.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SPC

Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Precept Management Dallas, Texas $126M AUM 36.77% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WAM

Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return

Capital World Investors's INAB Position: Q3 2022 in Review

Capital World Investors sold out of IN8bio (INAB) in Q3 2022, closing a stake of 25,825 shares — an estimated $1.88M sold.

Capital World Investors first reported a position in INAB in Q3 2021 and held it in 4 quarters. The position peaked at $5.52M in Q3 2021. 17 funds tracked by Wall St. Rank hold INAB as of Q3 2022.

Capital World Investors reported no remaining IN8bio position as of Q3 2022 after selling out during the quarter.
Capital World Investors sold 25,825 IN8bio shares in Q3 2022, an estimated $1.88M.
Capital World Investors first reported a position in IN8bio in Q3 2021 and held it in 4 quarters.
Capital World Investors's IN8bio position peaked at $5.52M in Q3 2021.
17 funds tracked by Wall St. Rank held IN8bio as of Q3 2022.

Based on Capital World Investors's 13F filing for Q3 2022, filed 14 Nov 2022.